Recombinant activated factor VII for adjunctive hemorrhage control in trauma – Discussion.
Holcomb J, Mattox KL, Schreiber MA, Martinowitz U
J Trauma 2001;51(3):438-439.
Review by M. Aldouri
Recombinant activated factor VII (RFVIIa): Characterization, manufacturing, and clinical development.
Jurlander B, Thim L, Klausen NK, et al.
Semin Thromb Hemostasis 2001;27(4):373-383.
Review by M. Aldouri
New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
Kessler CM
Curr Opin Hematol 2000;7(6):408-413.
Review by M. Aldouri
Sitemap
Contact us
- +33 144 015 181
- scwd@mededgs.com
-
SCWD
c/o Intercomptas fiduciaire Sàrl
Vers-chez-les-Blanc, route du Jorat 67 1000 Lausanne 26
Switzerland
Copyright © 2009 – 2022 Society on Sarcopenia, Cachexia and Wasting Disorders. All Rights Reserved. Data Privacy